ARCHIVES

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

New Grants Awarded In Tobacco Research

February 17, 1978

Working Group To Review NCI Clinical Trials Programs

April 12, 1996

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

More Aggressive Prevention, Detection Could Save Lives, Cancer Policy Board Says

March 28, 2003

First shakeup In Upton Regime: Peters Moves Out As DCCP Head To Become “Special Assistant”

September 30, 1977

NCI To Offer Planning Grants for New Centers

November 9, 1990